Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Gout | D006073 | EFO_0004274 | M10 | — | 4 | — | — | — | 4 |
Arthritis | D001168 | HP_0001369 | M05-M14 | — | 2 | — | — | — | 2 |
Hyperuricemia | D033461 | HP_0002149 | — | — | 2 | — | — | — | 2 |
Joint diseases | D007592 | HP_0003040 | M12.9 | — | 2 | — | — | — | 2 |
Renal insufficiency | D051437 | HP_0000083 | N19 | — | 1 | — | — | — | 1 |
Psoriasis | D011565 | EFO_0000676 | L40 | — | 1 | — | — | — | 1 |
Drug common name | ULODESINE |
INN | ulodesine |
Description | Ulodesine is a small molecule pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | O=c1[nH]cnc2c(CN3C[C@H](O)[C@@H](CO)C3)c[nH]c12 |
PDB | — |
CAS-ID | 548486-59-5 |
RxCUI | — |
ChEMBL ID | CHEMBL269864 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | JNG8L9460Y (ChemIDplus, GSRS) |